1. Home
  2. CRBU vs AMTX Comparison

CRBU vs AMTX Comparison

Compare CRBU & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • AMTX
  • Stock Information
  • Founded
  • CRBU 2011
  • AMTX 2005
  • Country
  • CRBU United States
  • AMTX United States
  • Employees
  • CRBU N/A
  • AMTX N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • AMTX Major Chemicals
  • Sector
  • CRBU Health Care
  • AMTX Industrials
  • Exchange
  • CRBU Nasdaq
  • AMTX Nasdaq
  • Market Cap
  • CRBU 93.0M
  • AMTX 96.3M
  • IPO Year
  • CRBU 2021
  • AMTX N/A
  • Fundamental
  • Price
  • CRBU $1.36
  • AMTX $2.19
  • Analyst Decision
  • CRBU Strong Buy
  • AMTX Strong Buy
  • Analyst Count
  • CRBU 4
  • AMTX 4
  • Target Price
  • CRBU $8.50
  • AMTX $13.43
  • AVG Volume (30 Days)
  • CRBU 1.2M
  • AMTX 918.6K
  • Earning Date
  • CRBU 08-05-2025
  • AMTX 07-31-2025
  • Dividend Yield
  • CRBU N/A
  • AMTX N/A
  • EPS Growth
  • CRBU N/A
  • AMTX N/A
  • EPS
  • CRBU N/A
  • AMTX N/A
  • Revenue
  • CRBU $9,918,000.00
  • AMTX $237,892,000.00
  • Revenue This Year
  • CRBU $12.83
  • AMTX $27.78
  • Revenue Next Year
  • CRBU N/A
  • AMTX $91.59
  • P/E Ratio
  • CRBU N/A
  • AMTX N/A
  • Revenue Growth
  • CRBU N/A
  • AMTX N/A
  • 52 Week Low
  • CRBU $0.66
  • AMTX $1.22
  • 52 Week High
  • CRBU $3.00
  • AMTX $4.73
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 62.05
  • AMTX 65.90
  • Support Level
  • CRBU $1.12
  • AMTX $2.11
  • Resistance Level
  • CRBU $1.33
  • AMTX $2.39
  • Average True Range (ATR)
  • CRBU 0.11
  • AMTX 0.14
  • MACD
  • CRBU 0.00
  • AMTX 0.03
  • Stochastic Oscillator
  • CRBU 79.49
  • AMTX 66.03

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: